| Amount | Holding |
|---|---|
| 4.94% | Vertex Pharmaceuticals Inc |
| 4.81% | UnitedHealth Group Inc |
| 4.03% | DexCom Inc |
| 3.62% | Eli Lilly and Co |
| 3.07% | Bristol-Myers Squibb Company |
| 2.96% | Gilead Sciences Inc |
| 2.93% | Tolero Cdr/Rec |
| 2.87% | AbbVie Inc |
| 2.79% | Sarepta Therapeutics Inc |
| 2.74% | Danaher Corp |
Expense Ratio Rating
1 /10
Expense Rating
0 /10
Market Score
3 /10
Category Score
0 /10
Market Size
3 /10
$AHSCX Alternatives
14%
FI Score
- ahscx
- Mutual Fund
- Sector Equity
- Healthcare
Alger Health Sciences Fund Class C
Expenses: 1.89% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why ยป